Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
BioSpace
May 27, 2021
BioSpace
Biorasi, a leading global full-service contract research organization, is proud to announce the appointment of Alex A. Adjei, MD, PhD, FACP to the position of Scientific Advisory Board member.
May 21, 2021
BioSpace
RYBREVANTTM (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations - read this article along with other careers information, tips and advice on BioSpace
Janssen Pharmaceutical Companies of Johnson & Johnson
May 21, 2021
www.prnewswire.com:443
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the...
National Comprehensive Cancer Network
September 17, 2019
www.prnewswire.com:443
PLYMOUTH MEETING, Pa., Sept. 17, 2019 /PRNewswire/ -- New research in the September 2019 issue of JNCCN--Journal of the National Comprehensive Cancer Network...
Bio Ascend
August 27, 2019
www.prnewswire.com:443
SANTA MONICA, Calif., Aug. 27, 2019 /PRNewswire/ -- Nearly 46 percent of medical school graduates are women, yet women physicians remain underrepresented in...
Reportlinker
Invalid Date
www.prnewswire.com:443
NEW YORK, Feb. 18, 2019 /PRNewswire/ -- This report analyzes the worldwide markets for Nuclear Medicine Imaging Equipment in US$ Thousand by the following...
January 8, 2019
WebWire
AstraZeneca is announcing organisational changes to support continued scientific innovation and commercial success in the main therapy areas as the Company enters a new phase in its strategic development. Included in the changes will be the arrival at AstraZeneca of the world-renowned oncology scientist, José Baselga, as well as the creation of: , , , , , , • Therapy area-focused Research and Development units that are responsible for discovery through to late-stage development - one for BioPh...
December 7, 2018
WebWire
AstraZeneca and MedImmune, its global biologics research and development arm, announced overall survival (OS) results for the Phase III EAGLE trial. EAGLE is a randomised, open-label, multi-centre trial evaluating Imfinzi (durvalumab) monotherapy or Imfinzi in combination with tremelimumab, an anti-CTLA4 antibody, versus standard-of-care (SoC) chemotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who experienced disease progression follow...
